Literature DB >> 7528763

Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice.

J D Mountz1, T Zhou, H Bluethmann, J Wu, C K Edwards.   

Abstract

Although autoreactive T cells are thought to play a prominent role in autoimmune disease in MRL-lpr/lpr mice, it has been difficult to directly determine if autoreactive T cells escape from the thymus and react with self-antigens in the periphery. Defective expression of the Fas apoptosis antigen in MRL-lpr/lpr mice results from the insertion of the ETn retrotransposon. The fas defect can be partially corrected in CD2-fas transgenic mice in which the expression of fas is corrected in T cells. To identify a possible defect in clonal deletion or clonal anergy induction of auto-specific T cells, we have studied C57BL/6-lpr/lpr transgenic mice that express TcR genes that recognize a known self-antigen, the male H-Y antigen. In addition, we have analyzed clonal deletion and tolerance induction after neonatal tolerance induction and superantigen-induced arthritis with the class II MHC reactive superantigen staphylococcal enterotoxin B (SEB) in V beta 8 TcR transgenic and non-transgenic MRL-lpr/lpr mice. Neonatal tolerance induction to SEB was normal in lpr/lpr mice. However, over time a loss of tolerance (thymic or peripheral) was observed in lpr/lpr mice but not in +/+ TcR transgenic mice. This defect in lpr/lpr mice was thymic-dependent and was due to increased CD28/CTLA4 signaling. These results suggest that an apoptosis defect involving both thymocytes and peripheral lymphoid cells leads to autoimmune disease in lpr/lpr mice. The challenge in the future will be to determine the role of defective apoptosis in other autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528763     DOI: 10.3109/08830189409051178

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  9 in total

1.  Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.

Authors:  M W Bennett; J O'connell; G C O'sullivan; D Roche; C Brady; J Kelly; J K Collins; F Shanahan
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 2.  Regulation of apoptosis in immune cells.

Authors:  J D Mountz; T Zhou; J Wu; W Wang; X Su; J Cheng
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

3.  Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege.

Authors:  J O'Connell; M W Bennett; G C O'Sullivan; J O'Callaghan; J K Collins; F Shanahan
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

4.  A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis.

Authors:  J Zhang; A Winoto
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

5.  Corticotropin-releasing hormone (CRH) is expressed in the human cervical carcinoma cells (HeLa) and upregulates the expression of Fas ligand.

Authors:  Eirini Taliouri; Thomas Vrekoussis; Aikaterini Vergetaki; Theodore Agorastos; Antonis Makrigiannakis
Journal:  Tumour Biol       Date:  2012-10-18

6.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.

Authors:  K Song; Y Chen; R Göke; A Wilmen; C Seidel; A Göke; B Hilliard; Y Chen
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

Review 7.  Viruses, host responses, and autoimmunity.

Authors:  M S Horwitz; N Sarvetnick
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

8.  Mouse models of lupus: what they tell us and what they don't.

Authors:  Mara Lennard Richard; Gary Gilkeson
Journal:  Lupus Sci Med       Date:  2018-01-21

9. 

Authors:  Marc S Horwitz; Nora Sarvetnick
Journal:  Ann Inst Pasteur Actual       Date:  2000-03-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.